CIK 0001774857 · <br>Emerging growth company
Aardvark Therapeutics, Inc.
Sign in to watch- Ticker
- AARD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821606367
- Phone
- (858) 225-7696
- Business address
- 4370 LA JOLLA VILLAGE DRIVE, SUITE 1050, SAN DIEGO, CA, 92122
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Planned sale See Remarks sold 76,754 shares at an average $5.15 ($394,957)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 3,000 shares at $14.40 ($43,200)
- 4 Open-market buy Chief Executive Officer bought 7,000 shares at $14.49 ($101,395)
- 4 Option exercise Chief Executive Officer acquired 1,229 shares (option exercise)
- 4 Option exercise Chief Operating Officer acquired 1,250 shares (option exercise)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $9.66 ($96,624)
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at an average $8.03 ($160,654)
- 4 Open-market buy Chief Financial Officer bought 6,000 shares at $8.07 ($48,440)
Page 1 of 3 · 46 filings